Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCH-12 for newly diagnosed pediatric and young adult Langerhans cell histiocytosis
jRCTs041190006Phase 2Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Jul 2012
- Countries
- 1
01
Overview
Phase 2, open-label trial in Langerhans cell histiocytosis (LCH) (3 arms), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Event-free survival rates in different type of disease. Started Jul 2012; status: completed.
02
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on jRCTs041190006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190006.